Les plus populaires - CRVO 25 year old man - Factor V Leiden Heterozygous 25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 551 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 521 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 486 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 485 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 476 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 471 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 461 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 453 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 448 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 441 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 440 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 438 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 437 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 437 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 434 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 431 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 430 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 428 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 421 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 421 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 419 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 417 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 416 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 415 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 395 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy